Browsing Tag
Zydus Lifesciences
92 posts
Game-changing MRI technology: Zynext Ventures bets big on Neuro42’s brain imaging
Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences, has made a significant investment in Neuro42…
August 15, 2024
Zydus Lifesciences receives tentative FDA approval for Azilsartan Medoxomil Tablets
Zydus Lifesciences Limited has achieved a significant milestone with the tentative approval from the United States Food and…
July 4, 2024
Zydus Lifesciences gains tentative FDA approval for hypertension drug
Zydus Lifesciences Limited has achieved a significant milestone by receiving tentative approval from the United States Food and…
June 14, 2024
Zydus Lifesciences wraps up enrollment for Phase II ALS trial of Usnoflast
Zydus Lifesciences, a renowned global pharmaceutical company, has achieved a significant milestone by completing the enrollment for the…
May 24, 2024
Zydus Lifesciences reports Rs 19,547.4cr revenue from operations in FY24
Zydus Lifesciences Limited has released its financial results for the fourth quarter and the full fiscal year of…
May 17, 2024
Bayer Pharmaceuticals secures full ownership of JV with Zydus Lifesciences
Bayer Pharmaceuticals Private Limited will secure full ownership of Bayer Zydus Pharma Private Limited (BZPPL) after concluding its…
May 4, 2024
Zydus Lifesciences launches Mirabegron Extended-Release Tablets in US market
Zydus Lifesciences Limited has announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the US market, following…
April 23, 2024
Zydus Lifesciences announces WHO approval for NLRP3 inhibitor Usnoflast
Zydus Lifesciences, a discovery-based, global pharmaceutical leader, has recently received approval from the World Health Organization (WHO) International…
April 1, 2024
Zydus Lifesciences gains FDA aproval for Chlorpromazine Hydrochloride Injection
In a notable development for the pharmaceutical industry, Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has…
March 14, 2024
Zydus introduces cancer treatment IBYRA in India, making advanced therapy accessible
In a groundbreaking development for cancer treatment in India, Zydus Lifesciences has launched Olaparib under the brand name…
March 13, 2024